BioCentury | Sep 20, 2014
Financial News

Exagen files for IPO

Exagen Diagnostics Inc. (Vista, Calif.) filed to raise up to $69 million in an IPO on NASDAQ underwritten by Leerink; Baird; and William Blair. Exagen markets four products to diagnose rheumatic diseases. Its lead product,...
BioCentury | Jan 16, 2012
Company News

Exagen sales and marketing update

Exagen launched Avise SLE as an aid in diagnosing systemic lupus erythematosus (SLE). Avise SLE is a panel of five serum biomarkers for the differential diagnosis of SLE and rheumatic diseases. Exagen Diagnostics Inc. , Albuquerque,...
Items per page:
1 - 2 of 2